Tormod Kyrre Guren
Oslo University Hospital(NO)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics
Most-Cited Works
- → Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer(2019)1,423 cited
- → Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study(2012)528 cited
- → Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study(2021)518 cited
- → Portrait of the PI3K/AKT pathway in colorectal cancer(2014)322 cited
- → Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?(2014)199 cited
- → Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment(2013)143 cited
- → Combination therapies with HSP90 inhibitors against colorectal cancer(2019)117 cited
- → Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity(2020)116 cited
- → Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial(2023)111 cited
- → Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial(2021)101 cited